This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Cigna (CI) Receives a Buy from Guggenheim

Tipranks - Tipranks - Tue May 5, 6:20AM CDT

In a report released on May 1, Jason Cassorla from Guggenheim maintained a Buy rating on Cigna, with a price target of $338.00. The company’s shares closed last Friday at $282.90.

Claim 55% Off TipRanks

Cassorla covers the Healthcare sector, focusing on stocks such as Cigna, Tenet Healthcare, and Universal Health. According to TipRanks, Cassorla has an average return of -1.3% and a 51.85% success rate on recommended stocks.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cigna with a $340.53 average price target, implying a 20.37% upside from current levels. In a report released yesterday, TD Cowen also maintained a Buy rating on the stock with a $338.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Based on Cigna’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $68.49 billion and a net profit of $1.65 billion. In comparison, last year the company earned a revenue of $65.5 billion and had a net profit of $1.32 billion

Read More on CI:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).